Literature DB >> 7611386

Effects of increased cortisol concentration on ovine fetal leucine kinetics and protein metabolism.

J R Milley1.   

Abstract

Fetal protein accretion decreases as gestation progresses, primarily because protein synthesis decreases. Also, glucocorticoid primarily because protein synthesis decreases. Also, glucocorticoid concentrations increase late in gestation, and restraint of growth is one of the most consistently noted effects of glucocorticoids. Therefore, this study was done to determine whether fetal protein accretion is decreased by increased cortisol concentration and whether such an effect might be due to decreased protein synthesis or increased proteolysis. Six days after surgery, fetal leucine and protein metabolism was measured in eight pregnant ewes (114-119 days of gestation) at normal and elevated cortisol concentrations. Arterial blood leucine concentration, fetal leucine disposal rate, and exogenous leucine uptake were unaffected by cortisol infusion. Fetal leucine decarboxylation, however, increased by 19% (P < 0.001). Increased fetal cortisol concentration increased fetal proteolysis by 11% (P < 0.001) but did not affect the use of leucine for protein synthesis. Consequently, fetal protein accretion fell by 34% (P < 0.002). We conclude that increased fetal plasma cortisol concentration increases fetal proteolysis, thereby decreasing the rate of fetal protein accretion, an effect different from the decreased protein synthesis reported in late gestation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7611386     DOI: 10.1152/ajpendo.1995.268.6.E1114

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  Prolonged infusion of amino acids increases leucine oxidation in fetal sheep.

Authors:  Anne M Maliszewski; Monika M Gadhia; Meghan C O'Meara; Stephanie R Thorn; Paul J Rozance; Laura D Brown
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-03-27       Impact factor: 4.310

2.  Acute supplementation of amino acids increases net protein accretion in IUGR fetal sheep.

Authors:  Laura D Brown; Paul J Rozance; Stephanie R Thorn; Jacob E Friedman; William W Hay
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-05-29       Impact factor: 4.310

3.  Chronic anemic hypoxemia attenuates glucose-stimulated insulin secretion in fetal sheep.

Authors:  Joshua S Benjamin; Christine B Culpepper; Laura D Brown; Stephanie R Wesolowski; Sonnet S Jonker; Melissa A Davis; Sean W Limesand; Randall B Wilkening; William W Hay; Paul J Rozance
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-01-18       Impact factor: 3.619

4.  Myoblast replication is reduced in the IUGR fetus despite maintained proliferative capacity in vitro.

Authors:  Susan M Soto; Amy C Blake; Stephanie R Wesolowski; Paul J Rozance; Kristen B Barthel; Bifeng Gao; Byron Hetrick; Carrie E McCurdy; Natalia G Garza; William W Hay; Leslie A Leinwand; Jacob E Friedman; Laura D Brown
Journal:  J Endocrinol       Date:  2017-01-04       Impact factor: 4.286

Review 5.  Metabolic Consequences of Glucocorticoid Exposure before Birth.

Authors:  Abigail L Fowden; Owen R Vaughan; Andrew J Murray; Alison J Forhead
Journal:  Nutrients       Date:  2022-05-30       Impact factor: 6.706

6.  The role of cortisol in chronic binge alcohol-induced cerebellar injury: Ovine model.

Authors:  Shannon E Washburn; Ursula Tress; Emilie R Lunde; Wei-Jung A Chen; Timothy A Cudd
Journal:  Alcohol       Date:  2012-12-05       Impact factor: 2.405

Review 7.  Challenges in nourishing the intrauterine growth-restricted foetus - Lessons learned from studies in the intrauterine growth-restricted foetal sheep.

Authors:  William W Hay; Laura D Brown; Paul J Rozance; Stephanie R Wesolowski; Sean W Limesand
Journal:  Acta Paediatr       Date:  2016-05-10       Impact factor: 2.299

8.  Adrenal glands are essential for activation of glucogenesis during undernutrition in fetal sheep near term.

Authors:  A L Fowden; A J Forhead
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-10-19       Impact factor: 4.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.